Unresectable Stage III Melanoma
4 clinical trials · Condition
◉ Watch Unresectable Stage III Melanoma
| Record | Firm | Date |
|---|---|---|
| Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib (NCT03235245) | European Organisation for Research and Treatment of Cancer - EORTC | 2018-10-30 |
| Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy (NCT03353402) | Sheba Medical Center | 2017-11-30 |
| RTA 408 Capsules in Patients With Melanoma - REVEAL (NCT02259231) | Biogen | 2014-10-31 |
| Phase 2 Study of the Poly(ADP-Ribose) Polymerase Inhibitor E7016 in Combination With Temozolomide in Subjects With Wild Type BRAF Stage IV or Unresectable Stage III Melanoma (NCT01605162) | Eisai Inc. | 2012-05-01 |
Track Unresectable Stage III Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.